Document Detail


Oral misoprostol use in early complicated pregnancy.
MedLine Citation:
PMID:  8863909     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Eighty-four patients with early complicated pregnancies such as intrauterine death, blighted ovum pregnancy and missed abortion were treated with oral misoprostol. If abortion did not occur, 200 micrograms misoprostol was given once an hour, with an average dose of 1000 micrograms (min 200 micrograms, max 1200 micrograms). Complete or partial abortion took place within 7.0 +/- 5.1 h in 92.5% of patients. Of the patients, 11.9% and 83.3% had complete and partial abortion, respectively, without major complications. We observed only minor side-effects such as nausea, vomiting, diarrhea, hypotension, fever, headache and abdominal pain. This study demonstrates that the use of oral misoprostol is a simple, inexpensive and easy procedure for terminating early complicated pregnancies, although additional surgical evacuation of the uterus was required in the large majority of patients.
Authors:
A Haberal; H Celikkanat; S Batioglu
Related Documents :
14981379 - A randomized trial of saline solution-moistened misoprostol versus dry misoprostol for ...
18624139 - Discrepancies in the laws on identifying foetal sex and terminating a pregnancy in india.
20227549 - Two medical abortion regimens for late first-trimester termination of pregnancy: a pros...
472339 - Intramuscular 16-phenoxy pge2 ester for pregnancy termination.
3370199 - Early pregnancy termination: a comparison between vacuum aspiration and medical abortio...
3919839 - Sequelae and support after termination of pregnancy for fetal malformation.
11933659 - Three-dimensional (3d) ultrasound--a useful imaging technique in the assessment of neon...
17962979 - Development of the human fetal insular cortex: study of the gyration from 13 to 28 gest...
8505669 - Folate catabolism is increased during pregnancy in rats.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Advances in contraception : the official journal of the Society for the Advancement of Contraception     Volume:  12     ISSN:  0267-4874     ISO Abbreviation:  Adv Contracept     Publication Date:  1996 Jun 
Date Detail:
Created Date:  1997-01-14     Completed Date:  1997-01-14     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8607435     Medline TA:  Adv Contracept     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  139-43     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, Social Security Association Hospital, Ankara, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal* / administration & dosage,  adverse effects
Abortion, Therapeutic*
Administration, Oral
Adult
Female
Gestational Age
Humans
Misoprostol* / administration & dosage,  adverse effects
Pregnancy
Pregnancy Complications*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59122-46-2/Misoprostol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Calendar rhythm efficacy: a review.
Next Document:  Chlamydia trachomatis detected in cervical smears from Copper-T users by DFA test.